AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33492872 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal oxygen (50 l min-1 and a 50:50 oxygen to air ratio)
Number of subjects: 129
Study 33492872 — intervention group
Group type: COMPARATOR
Intervention: Facemask oxygen (≥ 8 l min-1)
Number of subjects: 129
Study 33492872 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal oxygen
Number of subjects: 129
Study 33492872 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal oxygen and Facemask oxygen
Number of subjects: 129
Study 32438783 — intervention group
Group type: EXPERIMENTAL
Intervention: LH-TL group (live high-train low protocol)
Number of subjects: 34
Study 32438783 — intervention group
Group type: EXPERIMENTAL
Intervention: HiHiLo group (live high - base train high - interval train low procedure)
Number of subjects: 34
Study 32438783 — intervention group
Group type: EXPERIMENTAL
Intervention: IHT group (intermittent hypoxic training)
Number of subjects: 34
Study 32438783 — intervention group
Group type: COMPARATOR
Intervention: Control group (CN, normoxic training)
Number of subjects: 34
Study 32310854 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin therapy only
Number of subjects: 100
Study 32310854 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vildagliptin plus subcutaneous insulin
Number of subjects: 100
Study 35420380 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) applied before surgery and 1 month after surgery
Number of subjects: 162
Study 35420380 — intervention group
Group type: COMPARATOR
Intervention: Non-ESPB block (control group)
Number of subjects: 162
Study 33588077 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference-delivered cognitive behaviour therapy for insomnia (CBT-I)
Number of subjects: 124
Study 33588077 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 124
Study 35580898 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (HFNO)
Number of subjects: 364
Study 35580898 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy (COT)
Number of subjects: 364
Study 33410360 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct superior approach (DSA)
Number of subjects: 45
Study 33410360 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral approach (PL)
Number of subjects: 45
Study 33410360 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DSA and PL
Number of subjects: 45
Study 33460256 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment (SBP < 120 mm Hg)
Number of subjects: 9361
Study 33460256 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure treatment (SBP < 140 mm Hg)
Number of subjects: 9361
Study 34081137 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app intervention for 6 months
Number of subjects: 204
Study 34081137 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 204
Study 34081137 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app intervention for participants with HbA1c levels of 8% or higher
Number of subjects: 204
Study 32009299 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TFB application
Number of subjects: 15
Study 32009299 — intervention group
Group type: COMPARATOR
Intervention: Placebo application
Number of subjects: 15
Study 33496621 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs including clinical patients
Number of subjects: 212
Study 33496621 — intervention group
Group type: COMPARATOR
Intervention: Abstracts meeting CONSORT recommendations for title, participant eligibility criteria, primary outcome, randomization technique, blinding, numbers analyzed, primary outcome results, and harms to participants
Number of subjects: 212
Study 33496621 — intervention group
Group type: COMPARATOR
Intervention: Overall reporting quality of abstracts
Number of subjects: 212
Study 32084526 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver-directed concurrent chemoradiotherapy (LD-CCRT) and sequential sorafenib treatment (400 mg, twice daily)
Number of subjects: 47
Study 35289183 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (200 mg/kg) administered intravenously for 30 minutes after return of spontaneous circulation
Number of subjects: 38
Study 35289183 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study 34793552 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 16676
Study 34793552 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 16676
Study 34793552 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 16676
Study 34793552 — intervention group
Group type: COMPARATOR
Intervention: Age
Number of subjects: 16676
Study 34793552 — intervention group
Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 16676
Study 32192454 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in homes with chimney
Number of subjects: 5830
Study 32192454 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in homes with eaves space
Number of subjects: 5830
Study 32192454 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in homes with improved cookstove
Number of subjects: 5830
Study 32192454 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow dung fuel use
Number of subjects: 5830
Study 32192454 — intervention group
Group type: EXPERIMENTAL
Intervention: Child spending time near stove during cooking
Number of subjects: 5830
Study 32192454 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of extra indoor burning events
Number of subjects: 5830
Study 32192454 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent cooking of meals
Number of subjects: 5830
Study 33573391 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment strategies for healthcare providers
Number of subjects: 0
Study 33573391 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal recruitment strategies
Number of subjects: 0
Study 32792712 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES)
Number of subjects: 48
Study 32792712 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TES)
Number of subjects: 48
Study 34266522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase treatment (4 drops of lactase additive, 180 mg added into preterm formula or breast milk)
Number of subjects: 60
Study 34266522 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo, oral probiotics at half an hour after feeding, and abdominal massage)
Number of subjects: 60
Study 34366180 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital media-based hand therapy (self-directed, 12-week protocol)
Number of subjects: 49
Study 34366180 — intervention group
Group type: COMPARATOR
Intervention: Traditional hand therapy (12-week protocol)
Number of subjects: 49
Study 34747584 — intervention group
Group type: EXPERIMENTAL
Intervention: Pavlovian conditioning intervention (Progressive Muscle Relaxation paired with fruit intake)
Number of subjects: 100
Study 34747584 — intervention group
Group type: COMPARATOR
Intervention: Active explicitly unpaired control group (Progressive Muscle Relaxation and fruit intake not temporally paired)
Number of subjects: 100
Study 36245145 — intervention group
Group type: EXPERIMENTAL
Intervention: Galnobax 14% BID
Number of subjects: 4
Study 36245145 — intervention group
Group type: EXPERIMENTAL
Intervention: Galnobax 20% BID
Number of subjects: 4
Study 36245145 — intervention group
Group type: EXPERIMENTAL
Intervention: Galnobax 20% OD + vehicle
Number of subjects: 4
Study 36245145 — intervention group
Group type: COMPARATOR
Intervention: Vehicle BID
Number of subjects: 4
Study 33897958 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait-based (TB) scoring tool
Number of subjects: 10
Study 33897958 — intervention group
Group type: COMPARATOR
Intervention: Element-based (EB) scoring tool
Number of subjects: 10
Study 32376812 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app-based walking exercise program (12 weeks duration, includes education via app, 12 SMS, 1 individual counseling)
Number of subjects: 61
Study 32376812 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app-based walking exercise program
Number of subjects: 61
Study 32376812 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 61
Study 34549853 — intervention group
Group type: EXPERIMENTAL
Intervention: P11-4
Number of subjects: 154
Study 34549853 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridate toothpaste (FT)
Number of subjects: 154
Study 34549853 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP)
Number of subjects: 154
Study 34549853 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridate bioactive glass toothpaste (BT)
Number of subjects: 154
Study 34549853 — intervention group
Group type: EXPERIMENTAL
Intervention: P11-4 + CPP-ACP
Number of subjects: 154
Study 34549853 — intervention group
Group type: EXPERIMENTAL
Intervention: P11-4 + BT
Number of subjects: 154
Study 34549853 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 154
Study 34818617 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal HD-tDCS over parietal cortex and cerebellum
Number of subjects: 0
Study 34818617 — intervention group
Group type: COMPARATOR
Intervention: Cathodal HD-tDCS
Number of subjects: 0
Study 34818617 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 35029045 — intervention group
Group type: EXPERIMENTAL
Intervention: vilobelimab plus best supportive care
Number of subjects: 30
Study 35029045 — intervention group
Group type: COMPARATOR
Intervention: best supportive care only
Number of subjects: 30
Study 34828790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Music Therapy (MT) and Skin-to-Skin Care (SSC)
Number of subjects: 68
Study 34828790 — intervention group
Group type: COMPARATOR
Intervention: Skin-to-Skin Care (SSC) alone
Number of subjects: 68
Study 35086206 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2 mm clear corneal incision
Number of subjects: 130
Study 35086206 — intervention group
Group type: COMPARATOR
Intervention: 2.8 mm clear corneal incision
Number of subjects: 130
Study 35086206 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study 33839489 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal betamethasone drops (3 times daily for a maximum of one month)
Number of subjects: 276
Study 33839489 — intervention group
Group type: COMPARATOR
Intervention: Placebo (9% NaCl drops, similar dosage to betamethasone)
Number of subjects: 276
Study 33413936 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral internal thoracic arteries (BITAs)
Number of subjects: 0
Study 33413936 — intervention group
Group type: COMPARATOR
Intervention: Single internal thoracic arteries (SITAs)
Number of subjects: 0
Study 32911009 — intervention group
Group type: EXPERIMENTAL
Intervention: SDA treatment using resin bonded bridgework (RBB)
Number of subjects: 89
Study 32911009 — intervention group
Group type: COMPARATOR
Intervention: RDPs (removable dental prostheses)
Number of subjects: 89
Study 35590253 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1α ‐889C/T (rs1800587) polymorphism
Number of subjects: 54
Study 35590253 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐1β ‐511C > T (rs16944) polymorphism
Number of subjects: 54
Study 35590253 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFα ‐308G > A (rs1800629) polymorphism
Number of subjects: 54
Study 35590253 — intervention group
Group type: EXPERIMENTAL
Intervention: TNFα ‐238G > A (rs361525) polymorphism
Number of subjects: 54
Study 35590253 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6 ‐174G > C (rs1800795) polymorphism
Number of subjects: 54
Study 35590253 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6 ‐572G > C (rs1800796) polymorphism
Number of subjects: 54
Study 33386149 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal methylation-mRNA regulation chains identified through summary statistic data-based Mendelian randomization (SMR) analysis.
Number of subjects: 0
Study 33386149 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal inference test (CIT) performed on methylation-mRNA pairs.
Number of subjects: 0
Study 33386149 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNGR1 expression in peripheral blood mononuclear cells.
Number of subjects: 0
Study 33386149 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylations located in CpG Islands overlapping promoters in the 5′ region of the genes.
Number of subjects: 0
Study 32664074 — intervention group
Group type: EXPERIMENTAL
Intervention: Health belief model-based interventions
Number of subjects: 346
Study 32664074 — intervention group
Group type: COMPARATOR
Intervention: Conventional breastfeeding guidance
Number of subjects: 346
Study 35903763 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Enough Sex (GES)‐based, couple‐centered group counseling
Number of subjects: 100
Study 35903763 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 35723714 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive botanical patch applications (3 times on day 0 and once daily on days 1-6)
Number of subjects: 80
Study 35723714 — intervention group
Group type: COMPARATOR
Intervention: No additional therapy (SRP alone, control)
Number of subjects: 80
Study 35723714 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive botanical patch applications
Number of subjects: 80
Study 36053757 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg MTX subcutaneously
Number of subjects: 0
Study 36053757 — intervention group
Group type: COMPARATOR
Intervention: 8 mg MTX orally
Number of subjects: 0
Study 36053757 — intervention group
Group type: EXPERIMENTAL
Intervention: MJK101 (subcutaneous MTX)
Number of subjects: 0
Study 34649864 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic heparin
Number of subjects: 465
Study 34649864 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic heparin
Number of subjects: 465
Study 35775212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Counseling and Navigation (TCN)
Number of subjects: 641
Study 35775212 — intervention group
Group type: COMPARATOR
Intervention: Tailored Print (TP)
Number of subjects: 641
Study 35775212 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 641
Study 33041277 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral scanner (IOS)
Number of subjects: 40
Study 33041277 — intervention group
Group type: COMPARATOR
Intervention: Extraoral scanner (EOS)
Number of subjects: 40
Study 33041277 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolithic lithium disilicate ceramic (LM)
Number of subjects: 40
Study 33041277 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolithic zirconia (ZM)
Number of subjects: 40
Study 36071341 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives to promote service engagement
Number of subjects: 34
Study 33820463 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma GH levels measured using a competitive homologous enzyme-linked immunosorbent assay.
Number of subjects: 240
Study 33820463 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultradian (12 h) and 24 h rhythms of plasma GH.
Number of subjects: 240
Study 33820463 — intervention group
Group type: EXPERIMENTAL
Intervention: Mapping of acrophases of GH.
Number of subjects: 240
Study 33820463 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadosomatic index (GSI) of male catfish.
Number of subjects: 240
Study 33820463 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of plasma GH Mesors and acrophases between male and female catfish.
Number of subjects: 240
Study 36030801 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife group (sublingual misoprostol 400 μg every 3 hours for up to five doses)
Number of subjects: 1191
Study 36030801 — intervention group
Group type: COMPARATOR
Intervention: Physician group (sublingual misoprostol 400 μg every 3 hours for up to five doses)
Number of subjects: 1191
Study 34182933 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoFlow
Number of subjects: 80
Study 34182933 — intervention group
Group type: COMPARATOR
Intervention: VCV
Number of subjects: 80
Study 35322892 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 64
Study 35322892 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic band ligation (EBL)
Number of subjects: 64
Study 32086373 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence-contingent wage supplements
Number of subjects: 91
Study 32086373 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 91
Study 35856049 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral stimulation program
Number of subjects: 44
Study 35856049 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Number of subjects: 44
Study 35856049 — intervention group
Group type: COMPARATOR
Intervention: Routine newborn procedures (Control)
Number of subjects: 44
Study 35856049 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistimulation (combined oromotor and tactile stimulation)
Number of subjects: 44
Study 35856049 — intervention group
Group type: EXPERIMENTAL
Intervention: Oromotor stimulation
Number of subjects: 44
Study 33380362 — intervention group
Group type: EXPERIMENTAL
Intervention: Vial-and-syringe (V–S)
Number of subjects: 315
Study 33380362 — intervention group
Group type: EXPERIMENTAL
Intervention: Accessorized prefilled syringe (APFS)
Number of subjects: 315
Study 33380362 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoinjector (AI)
Number of subjects: 315
Study 33380362 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 315
Study 35260960 — intervention group
Group type: EXPERIMENTAL
Intervention: BPA plus education
Number of subjects: 22
Study 35260960 — intervention group
Group type: EXPERIMENTAL
Intervention: BPA only
Number of subjects: 22
Study 35260960 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 22
Study 35260960 — intervention group
Group type: EXPERIMENTAL
Intervention: BPA plus education (phase 2)
Number of subjects: 22
Study 35260960 — intervention group
Group type: EXPERIMENTAL
Intervention: BPA only (phase 2)
Number of subjects: 22
Study 33846362 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning methods (extremely randomized trees) for predicting postpartum depression
Number of subjects: 4313
Study 33846362 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning methods (extremely randomized trees) for predicting postpartum depression among women without previous depression
Number of subjects: 4313
Study 36345347 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sildenafil dosed every 8 hours for up to 34 days at doses of 0.125, 0.5, and 1 mg/kg/dose in cohorts 1, 2, and 3, respectively.
Number of subjects: 0
Study 36345347 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral sildenafil dosed every 8 hours for up to 34 days at doses double the IV doses.
Number of subjects: 0
Study 36345347 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 0
Study 32422538 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT (computer-delivered CBT) plus brief monitoring
Number of subjects: 205
Study 32422538 — intervention group
Group type: COMPARATOR
Intervention: In-person CBT
Number of subjects: 205
Study 32422538 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 205
Study 32422538 — intervention group
Group type: COMPARATOR
Intervention: CBT4CBT plus TAU
Number of subjects: 205
Study 32422538 — intervention group
Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 205
Study 36287562 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet intervention (target <40 net grams of carbohydrates during the first 3 months; <60 net grams for months 3 to 6) with dietary counseling
Number of subjects: 150
Study 36287562 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 150
Study 33444529 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionation (42.7 Gy in seven fractions, 3 days per week for 2.5 weeks)
Number of subjects: 1180
Study 33444529 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation (78.0 Gy in 39 fractions, 5 days per week for 8 weeks)
Number of subjects: 1180
Study 33444529 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionation
Number of subjects: 1180
Study 33444529 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation
Number of subjects: 1180
Study 35815354 — intervention group
Group type: EXPERIMENTAL
Intervention: BFF MDI (budesonide/formoterol fumarate dihydrate metered dose inhaler) 320/10 µg with a spacer
Number of subjects: 30
Study 35815354 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD/FORM DPI (budesonide/formoterol fumarate dry powder inhaler) 320/9 µg
Number of subjects: 30
Study 32746598 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia (group CS)
Number of subjects: 160
Study 32746598 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia (group DS)
Number of subjects: 160
Study 32746598 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia (group CW)
Number of subjects: 160
Study 32746598 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia (group DW)
Number of subjects: 160
Study 32331356 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time video communication software
Number of subjects: 430
Study 32331356 — intervention group
Group type: COMPARATOR
Intervention: Telephone
Number of subjects: 430
Study 35426903 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS+ERS
Number of subjects: 0
Study 35426903 — intervention group
Group type: COMPARATOR
Intervention: ERS alone
Number of subjects: 0
Study 35426903 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 33778945 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 or 54 mg of extended-release methylphenidate
Number of subjects: 94
Study 33778945 — intervention group
Group type: COMPARATOR
Intervention: Placebo (after gradual withdrawal from methylphenidate)
Number of subjects: 94
Study 36122564 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-initiated exercise
Number of subjects: 115
Study 36122564 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation techniques
Number of subjects: 115